NewsPronto

 
Times Advertising


.

PR Newswire

PIVALATE ACHIEVES POSITIVE PHASE 2 DATA IN BRAIN METS TRIAL

  • Written by PR Newswire Asia - News Pronto RSS
image
  • F-18 Pivalate PET shows high uptake regardless of origin of primary tumour
  • F-18 Pivalate can be used to monitor cerebral metastases
  • Patients without previous external beam radiation show higher tumour uptake, while those previously treated show a trend towards lower uptake

MELBOURNE, Australia, Oct. 19, 2022 /PRNewswire/ -- Radiopharm Theranostics...

Read more: PIVALATE ACHIEVES POSITIVE PHASE 2 DATA IN BRAIN METS TRIAL

More Articles ...

  1. Strategic Partnership Agreement to Develop the Quantum Computing Market in Japan and Asia-Pacific
  2. Adsterra Publishers and Affiliates Can Now Withdraw Payouts in Local Currencies Via Hyperwallet (by PayPal)
  3. REYL INTESA SANPAOLO CALLS FOR SHIFT IN EDUCATION WITH LAUNCH OF FORWARD PUBLICATION
  4. Eviosys: Consumers choose metal packaging and tinned food to support sustainability and cost-of-living
  5. Cattle Dog Digital, RevOps Practitioners Chosen for Newchip's Seed-Stage Global Accelerator Program